Benign Neoplasms

A benign tumor is an abnormal but noncancerous collection of cells also called a benign neoplasm. Benign tumors can form anywhere on or in your body, but many don’t need treatment. Talk to a healthcare provider if you have any unusual growth, signs of a possible tumor or changes in symptoms.

02xl is your source for accurate and trustworthy information so you can make the best choices for your health and wellness.

PS: Please note that 02xl provides this information for the benefit of the rare disease and overweight community. 02xl is not a medical provider or health care facility and thus can neither diagnose any disease or disorder nor endorse or recommend any specific medical treatments. Patients must rely on the personal and individualized medical advice of their qualified health care professionals before seeking any information related to their particular diagnosis, cure or treatment of a condition or disorder.

Latest Benign Neoplasms News

FDA Approves Ogsiveo, a Groundbreaking Treatment for Desmoid Tumors

A Game-Changer in the Treatment of Desmoid Tumors The US Food and…

Zara Nwosu Zara Nwosu

Therapeutic Access and Emerging Treatments

This is a video synopsis/summary of a Peer Exchange involving Ryan Haumschild,…

02xl Admin 02xl Admin

Strategic Desmoid Tumor Education and Access

This is a video synopsis/summary of a Peer Exchange involving Ryan Haumschild,…

02xl Admin 02xl Admin

Multiple Facial Papules | MDedge Dermatology

The Diagnosis: Birt-Hogg-Dubé Syndrome Histopathologic examination revealed a collection of bland spindle…

02xl Admin 02xl Admin

Teen with rare tumor advocates for mental health awareness

GRAND RAPIDS, MI – A year ago, Gabe Augdahl struggled with not…

Immunome wins Ayala’s Phase III desmoid tumour candidate for $50m

Immunome will pay $20m upfront and $30m in common stock. A further…

Robert Barrie Robert Barrie

NCCN Guidelines and Treatment Insights for Desmoid Tumors

This is a video synopsis/summary of a Peer Exchange involving Ryan Haumschild,…

02xl Admin 02xl Admin

Immunome (IMNM) to Acquire Desmoid Tumor Candidate, Stock Up

Shares of Immunome, Inc. IMNM were up 36.9% on Feb 6 after…

Zacks Equity Research Zacks Equity Research

Immunome wins Ayala’s Phase III desmoid tumour candidate for $50m

Immunome will pay $20m upfront and $30m in common stock. A further…

Robert Barrie Robert Barrie